Blauer Manufacturing announced on June 11th that it received formal 3^rd party certification for its new BIO-99™ coverall to the NFPA 1999 Standard on Protective Clothing and Ensembles for Emergency Medical Operations for multiple-use (...

The Tiki Respiratory Protection Mask

Tiki was developed in Sweden, intended for use in demanding settings with the highest requirements of protection against airborne particles and bacteria. The Tiki mask is reusable, has self-adjusting ventilation and is operated with batteries. The

A new California lawsuit is part of 3M’s global effort to combat fraud and price gouging and help protect the public against those exploiting the demand for critical products during the pandemic.

3M filed a legal action on June 8th in federal court in California, asserting that a seller

SIGA Technologies, Inc. today announced its first international delivery of TPOXX (tecovirimat), with 2,500 courses delivered to the Canadian Department of National Defence (CDND).  On April 3, 2020, the Company previously announced that the CDND is expected to purchase up

Two Lawrence Livermore National Laboratory (LLNL) researchers who have worked for more than eight years to develop a tularemia vaccine are part of a three-institution team that has been funded to bring their candidate

GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine adjuvant system, in 2021, to support the development of multiple adjuvanted COVID-19 vaccine candidates.

GSK today confirmed its intention to manufacture 1 billion doses of its pandemic vaccine

A new coalition of more than 500 scientists from around the world has been created to share data on COVID-19 gleaned from the use of mass spectrometry techniques which examine people’s blood and other biomarkers.

Announced in ...

Through innovation, hard work and a $200,000 grant from the National Science Foundation, a research team led by chemistry Prof. Omar Farha will work to develop a reusable, virus-deactivating face mask for healthcare workers on the frontlines of the COVID-19 pandemic.

According to a May

After reaching a landmark agreement with the University of Oxford today for the global development and distribution of the University’s potential recombinant adenovirus vaccine aimed at preventing COVID-19 infection from SARS-CoV-2, AstraZeneca have now committed to at least 400 million

The isolation pod known as the EpiShuttle has finally reached France for evaluation from professional caretakers and medical transport. France is still comping with a large amount of corona patients and high rates of critical cases.

The EpiShuttle is already in service with The

Zeteo Biomedical LLC, Inc., a privately held, medical device company, in collaboration with the Nanovaccine Institute at Iowa State University, has been awarded a five year NIH grant to develop a room temperature stable, universal nasal flu vaccine. Zeteo will provide nasal delivery device

Federal Resources Supply Company was selected by the Defense Logistics Agency (DLA) to deliver kits of life-saving Personal Protective Equipment (PPE) to approximately 15,000 nursing homes across America. Responding to a request from the Federal Emergency Management Agency (FEMA) and in

On April 21 a joint Air Force team, led by the Air Force Life Cycle Management Center and the Air Force’s CBRN Defense Systems Branch, delivered a rapidly developed containment system prototype that will enable as many as 28 COVID-positive patients to be transported aboard a C-17 in response to

Sanofi and GSK today announce that they have signed a letter of intent to enter into a collaboration to develop an adjuvanted vaccine for COVID-19,

The University of Manchester is repurposing specialised equipment across its campus to help produce safety equipment for NHS workers battling COVID-19 in an attempt to help reduce the critical demand across the region.

In a combined effort with other universities, including Salford and

From next week, two DRF Luftrettung stations in Germany will be using “EpiShuttles”, a special insulation stretcher. Another eight stations are to follow soon.

DRF Luftrettung invests in the protection of patients and their crews so that they can continue to help people in medical

Biobeat, an end-to-end medical grade monitoring system for the management of patients and individuals from a distance is currently being utilised in 14 Israeli hospitals as the main monitoring solution in COVID-19 isolation units as part of the effort by the Israeli Ministry of Health to combat

The Department of Homeland Security (DHS) Science and Technology Directorate (S&T) is conducting ongoing research that will help scientists better understand the coronavirus that causes the

Southwest Research Institute has received funding from the Medical CBRN Defense Consortium (MCDC) administered by Advanced Technology International to develop a nerve agent antidote for emergency use on the battlefield or to protect public health.

The use of nerve agents continues to be

PharmaJet, the maker of innovative, needle-free injection technology, announced that it received a $9.6 million dollar contract award from the Joint Science and Technology Office of the U.S. Defense Threat Reduction Agency

 Nobio Ltd. and Supergum (1983) Ltd. today announced an agreement to rapidly prototype and test an antiviral protective mask, combining

INOVIO Pharmaceuticals, Inc. (NASDAQ:INO) announced today that it has received a new $5 million grant from the Bill & Melinda Gates Foundation to accelerate the testing and scale up of CELLECTRA® 3PSP proprietary smart device for the intradermal delivery of INO-4800, a DNA vaccine for

The  Disaster Information Management Research Center ...

Merckhas confirmed that ERVEBO has now been registered by National Health Authorities in the following countries in Africa – DRC, Burundi, Ghana, and Zambia. 

ERVEBO was granted a conditional marketing authorization by the European Commission on November 11, 2019 and approved by

From Department of Homeland Security S&T news

The U.S. Coast Guard is

“What we have developed is like a living Velcro that removes and traps pathogens”

Nature-inspired wipes and masks which could capture and trap the Wuhan Coronavirus (2019-nCoV) are being developed by scientists at the Irish company Aquila Bioscience. This technology can be used

Story from NIH 

A Phase 1 clinical trial testing the safety and effectiveness of a monoclonal antibody (mAb) against malaria has

• The M72/AS01_E tuberculosis vaccine candidate demonstrated in a phase IIb trial the potential to reduce active pulmonary TB by half in adults with latent TB infection.

• Developing a new vaccine against TB is a

Inovio Pharmaceuticals, USA has announced the Coalition for Epidemic Preparedness Innovations (CEPI) has awarded Inovio a grant of up to $9 million to develop a vaccine against the recently emerged strain of coronavirus (2019-nCoV). This initial CEPI funding will support Inovio's

Elmon  is a leading manufacture of Ballistic (bulletproof) protection. For the last five years Elmon have been working on developing and adding CBRN suits to be included with its products, and are proud about the launching their very own CBRN protection suite with respirator,

The Partnership for Research on Ebola Vaccination (PREVAC) has launched a project called PREVAC-UP with the aim of evaluating three Ebola vaccine regimens for five years after vaccination.

The study will assess several factors of these treaments

• long-term

SIGA Technologies, Inc. today announced that the Canadian Department of National Defence (CDND) has issued an advanced contract award notice (ACAN), indicating that it intends to award a contract to fund regulatory filing with Health Canada for approval of oral TPOXX®. 

David Norquist, the U.S. Deputy Defense Secretary, has said that American Defense firms should not be cut out of European Union programs to strengthen its industrial base, such as the European Defence Fund and the Permanent Structured Cooperation program. 

Speaking at the

Merck , known as MSD outside the United States and Canada, today announced that the European Commission has granted a conditional marketing authorization to ERVEBO for active immunization of individuals 18 years of age or older to protect against Ebola Virus Disease (EVD) caused by Zaire Ebola

The two-day Chemical Weapons Demilitarisation (CWD) conference supports the global effort to eliminate chemical weapons and fosters co-operation through the exchange of information and ideas relating to safe disposal.

The next CWD Conference will be held in May 2020, London. In addition

Avon Protection is pleased to announce that the UK MOD General Service Respirator (‘GSR’) is now in production and work has begun to deliver the first order.

Avon Protection was awarded the 5-year contract to resupply and in-service support for the GSR in February 2018. After a year of

Original story from the Pasteur Institute

The Yersinia genus covers a vast range of bacteria that are distinguished by criteria such as whether or not

GlaxoSmithKline plc has announced the divestment of travel vaccines Rabipur (tradename Rabavert in the US) for the prevention of rabies, and Encepur for the prevention of tick-borne encephalitis, to Bavarian Nordic.

The decision to divest these brands, acquired from Novartis in 2015 as

Porton Biopharma Ltd (PBL) has today announced that it has signed a modification to its contract (HHSN272201600045C) with the US National Institute of Health’s National Institute of Allergy and Infectious Diseases

The Center for Devices and Radiological Health (CDRH) of the Food and Drug Administration (FDA) on Thursday allowed the marketing of the first rapid diagnostic test for the Ebola virus that has not been authorized via the agency’s Emergency Use Authorization (EUA) pathway.
...

The National Institute for Occupational Safety and Health (NIOSH) has released a new virtual toolkit to help first responders reduce their exposure to fentanyl and other illicit drugs. The toolkit provides resources to help keep first responders safe when arriving on a scene where illicit

FLIR Systems, Inc. has announced that it has acquired the intellectual property (IP) and certain operating assets of Aria Insights, Inc. Terms of the deal are not being disclosed.

Previously known as CyPhy Works, Inc., Aria pioneered the development of tethered small unmanned aerial

The Sabin Vaccine Institute (Sabin) has announced a funding award of $20.5 million with options for an additional $107.5 million from the Biomedical Advanced Research and Development Authority (BARDA) within the U.S. Department of Health and Human Services. Under the terms of this agreement,

SIGA Technologies, Inc. announced on October 3rd that it has reached concurrence with the US Food and Drug Administration (FDA) that no further clinical studies will be required for the IV formulation of TPOXX (tecovirimat), and SIGA anticipates filing the New Drug Application (NDA) for this

It was annonuced on September 24th that the Biomedical Advanced Research and Development Authority (BARDA) intends to provide $14 millio, as well as expertise support for the advanced development of an investigational Ebola treatment being pursued by Ridgeback Biotherapeutics of

The FDA has approved the Jynneos vaccine by Bavarian Nordic for the prevention of Smallpox and Monkeypox in adults 18 years of age and older determined to be at high risk for these infections.

Jynneos is a live vaccine produced from the strain Modified Vaccinia Ankara-Bavarian Nordic

Emergent BioSolutions Inc.  announced on September 25th that it has been awarded approximately $20 million to develop and manufacture an auto-injector containing diazepam (5 mg/mL) to treat nerve agent-induced seizures. Emergent’s device is being designed for intramuscular

BioFactura, Inc. announced on September 26th a contract awarded by the Biomedical Advanced Research and Development Authority (BARDA) valued at up to $67.4 million for the advanced development of its Smallpox Biodefense Therapeutic as a potential medical countermeasure (MCM) for the treatment

Scientists at the Lawrence Livermore National Laboratory have been working with live agent, supercomputers, and accelerated mass spectrometry, to develop a new nerve agent antidote, namely LLNL-02. 

Their work has been showing great promise, and with somw refinement of

The U.S. Department of Health and Human Services (HHS) announced this week that they will be purchasing a smallpox vaccine, called ACAM2000, to build and replenish vaccine stored in the ...